KWALITY PHARMACEUTICALS
Back to Income Statement
|
KWALITY PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹24 Cr | ₹19 Cr | ₹120 Cr | ₹15 Cr | ₹8.32 Cr |
What is the latest Consolidated Net Profit of KWALITY PHARMACEUTICALS ?
Year | Consolidated Net Profit |
---|---|
Mar2025 | ₹24 Cr |
Mar2024 | ₹19 Cr |
Mar2023 | ₹120 Cr |
Mar2022 | ₹15 Cr |
Mar2021 | ₹8.32 Cr |
How is Consolidated Net Profit of KWALITY PHARMACEUTICALS Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2025 | ₹24 Cr | 22.83 | |
Mar2024 | ₹19 Cr | -83.85 | |
Mar2023 | ₹120 Cr | 692.23 | |
Mar2022 | ₹15 Cr | 82.11 | |
Mar2021 | ₹8.32 Cr | - |
Compare Consolidated Net Profit of peers of KWALITY PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KWALITY PHARMACEUTICALS | ₹996.2 Cr | -1.1% | -6.7% | 23.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,342.0 Cr | 3.4% | 1.3% | -11.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,555.0 Cr | 2.4% | 3.2% | 11.9% | Stock Analytics | |
CIPLA | ₹127,259.0 Cr | 1.8% | 1.9% | -5.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,898.0 Cr | 2.8% | -0.9% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,394.0 Cr | 1.7% | 6.2% | -0.3% | Stock Analytics |
KWALITY PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KWALITY PHARMACEUTICALS | -1.1% |
-6.7% |
23.2% |
SENSEX | 0.9% |
1.2% |
-0.4% |
You may also like the below Video Courses